Access cutting-edge melanoma treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Omaha at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluated as a monotherapy and in combination with Nivolumab in subjects with unresectable and metastatic melanoma.
Sponsor: Perspective Therapeutics
Check if you qualify for this melanoma clinical trial in Omaha, NE
If you're searching for melanoma treatment options in Omaha, NE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.